Congress poster: ISGE 2026 Effects of Elinzanetant on VMS Associated With Natural Menopause, Surgical Menopause, or Endocrine Therapy (P390)

Figshare 2026 Open access

Read full text
Authors: JoAnn V. Pinkerton, Fatima Cardoso, James A. Simon, Cecilia Caetano, Claudia Haberland, Nazanin Haseli Mashhadi, Kaisa Laapas, Ioanna Gkioni, Lineke Zuurman, Christian Seitz
DOI: 10.71943/bayer.figshare.31211173
Cited by: 0

Abstract

This poster reports the efficacy of elinzanetant by natural, surgical, and induced menopausal symptoms. Elinzanetant treatment resulted in numerically greater reductions in daily moderate-to-severe VMS frequency and severity vs placebo irrespective of the type of menopausal symptom

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Estrogen and related hormone effects Reproductive Health and Contraception

Publication details

Journal / source
Figshare
Publication date
4 March 2026
Language
EN